Brief: Avenue Therapeutics Prices $2.6 Million Underwritten Public Offering Of Common Stock
10/11/2021 02:31
Nov 9 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS PRICES $2.6 MILLION UNDERWRITTEN
PUBLIC
OFFERING OF COMMON STOCK
* SAYS OFFERING PRICED AT $1.34PER SHARE
Source text for Eikon: ID:nGNX1XrFsv
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary